Wilmington, DE, United States of America

Spencer Drummond, Jr


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1995-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Spencer Drummond, Jr.: Innovator in Pharmaceutical Chemistry

Introduction

Spencer Drummond, Jr. is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Drummond's work focuses on the development of advanced chemical processes.

Latest Patents

One of Drummond's latest patents is titled "Sequential benzylic oxidations of the naloxone ring system." This invention pertains to a process for preparing the 10-keto analogs of morphinan compounds. The process involves synthesizing a 3-methyl ether protected analog through selective phenolic methylation, followed by acetylation to protect the 6-hydroxyl group. The protected analog is then oxidized using cerium ammonium nitrate to yield the desired 10-ketomorphinan. Another significant patent is related to "Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines," showcasing his expertise in creating compounds with therapeutic potential.

Career Highlights

Throughout his career, Spencer Drummond, Jr. has worked with prominent companies in the pharmaceutical industry. Notable among these are Endo Pharmaceuticals Inc. and the DuPont Merck Pharmaceutical Company. His experience in these organizations has contributed to his development as an inventor and innovator in the field.

Collaborations

Drummond has collaborated with several professionals in his field, including Gary Avonn Cain and Jeffrey T. Billheimer. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Spencer Drummond, Jr. is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his commitment to advancing the field. His work continues to influence the development of new therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…